These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16470422)

  • 21. Hydroxyapatite-coated total hip arthroplasty: the impact on thigh pain and arthroplasty survival.
    Baltopoulos P; Tsintzos C; Papadakou E; Karagounis P; Tsironi M
    Acta Orthop Belg; 2008 Jun; 74(3):323-31. PubMed ID: 18686456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of arthroscopy in resurfacing arthroplasty of the hip.
    Khanduja V; Villar RN
    Arthroscopy; 2008 Jan; 24(1):122.e1-3. PubMed ID: 18182213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty.
    Beraudi A; Stea S; Cremonini S; Visentin M; Toni A
    Artif Organs; 2009 Jul; 33(7):538-43. PubMed ID: 19566730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sports after total hip replacement.
    Yun AG
    Clin Sports Med; 2006 Apr; 25(2):359-64, xi. PubMed ID: 16638497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of hydroxyapatite coating on risk of revision after primary total hip arthroplasty in younger patients: findings from the Danish Hip Arthroplasty Registry.
    Paulsen A; Pedersen AB; Johnsen SP; Riis A; Lucht U; Overgaard S
    Acta Orthop; 2007 Oct; 78(5):622-8. PubMed ID: 17966021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraoperative dislocation of the prosthetic femoral head into the pelvis during total hip arthroplasty.
    Ozkan K; Ugutmen E; Altintas F; Eren A; Mahirogullari M
    Acta Orthop Belg; 2008 Aug; 74(4):553-5. PubMed ID: 18811045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aseptic loosening of total hip arthroplasty: preliminary genetic investigation.
    Godoy-Santos AL; D'Elia CO; Teixeira WJ; Cabrita HB; Camanho GL
    J Arthroplasty; 2009 Feb; 24(2):297-302. PubMed ID: 18952406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal.
    Hinz B; Renner B; Brune K
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):552-60; quiz 1 p following 589. PubMed ID: 17906610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intestinal side effects of COX-2 inhibitors].
    Calvo N; Iversen E; Munck LK
    Ugeskr Laeger; 2006 Mar; 168(13):1343-4. PubMed ID: 16579892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective COX-2 inhibitors should be used judiciously in the presence of renal impairment.
    Bhowmik D; Tiwari SC
    J Indian Med Assoc; 2004 Apr; 102(4):225. PubMed ID: 15473294
    [No Abstract]   [Full Text] [Related]  

  • 31. Factors affecting aseptic loosening of 4750 total hip arthroplasties: multivariate survival analysis.
    Bordini B; Stea S; De Clerico M; Strazzari S; Sasdelli A; Toni A
    BMC Musculoskelet Disord; 2007 Jul; 8():69. PubMed ID: 17650301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implant survival after primary total hip arthroplasty due to childhood hip disorders: results from the Danish Hip Arthroplasty Registry.
    Thillemann TM; Pedersen AB; Johnsen SP; Søballe K;
    Acta Orthop; 2008 Dec; 79(6):769-76. PubMed ID: 19085493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periprosthetic malignancy as a mode of failure in total hip arthroplasty.
    O'Shea K; Kearns SR; Blaney A; Murray P; Smyth HA; McElwain JP
    J Arthroplasty; 2006 Sep; 21(6):926-30. PubMed ID: 16950053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboembolic cardiovascular risk among arthritis patients using cyclooxygenase-2-selective inhibitor or nonselective cyclooxygenase inhibitor nonsteroidal anti-inflammatory drugs.
    Spalding WM; Reeves MJ; Whelton A
    Am J Ther; 2007; 14(1):3-12. PubMed ID: 17303969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of risedronate on bone metabolism after total hip arthroplasty: a prospective randomised study.
    Kinov P; Tivchev P; Doukova P; Leithner A
    Acta Orthop Belg; 2006 Jan; 72(1):44-50. PubMed ID: 16570894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [History of hip arthroplasty].
    Płomiński J; Kwiatkowski K
    Pol Merkur Lekarski; 2007 Feb; 22(128):83-5. PubMed ID: 17598648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cementless CUT femoral neck prosthesis: increased rate of aseptic loosening after 5 years.
    Ender SA; Machner A; Pap G; Hubbe J; Grashoff H; Neumann HW
    Acta Orthop; 2007 Oct; 78(5):616-21. PubMed ID: 17966020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
    van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
    Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eight-year results of hydroxyapatite-coated hip arthroplasty.
    Chang JK; Chen CH; Huang KY; Wang GJ
    J Arthroplasty; 2006 Jun; 21(4):541-6. PubMed ID: 16781407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unconstrained tripolar implants for primary total hip arthroplasty in patients at risk for dislocation.
    Guyen O; Pibarot V; Vaz G; Chevillotte C; Carret JP; Bejui-Hugues J
    J Arthroplasty; 2007 Sep; 22(6):849-58. PubMed ID: 17826276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.